Pharmaceutical

XtalPi’s AI biologics discovery platform licensed to Janssen Biotech

XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen Biotech for advanced biotherapeutics development.

Oct 12, 2024 - 04:00
XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen Biotech for advanced biotherapeutics development.
Read the original article

Tags:

Previous Article

Roche wins first-line approval for PI3K inhibitor combo in breast cancer

Next Article

Activist investor Starboard cries foul play in exec U-turn at Pfizer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sotigalimab by Pyxis Oncology for Esophageal Cancer: Li...

Oct 27, 2023

Astellas and PeptiDream enter protein degrader discovery deal

Astellas and PeptiDream enter protein degrader discover...

Jul 25, 2023

Cipla and Glenmark initiate recall of certain products in the US

Cipla and Glenmark initiate recall of certain products ...

May 7, 2024